184 related articles for article (PubMed ID: 11375762)
1. Design of NAALADase inhibitors: a novel neuroprotective strategy.
Jackson PF; Slusher BS
Curr Med Chem; 2001 Jul; 8(8):949-57. PubMed ID: 11375762
[TBL] [Abstract][Full Text] [Related]
2. N-Acetylated alpha-linked acidic dipeptidase converts N-acetylaspartylglutamate from a neuroprotectant to a neurotoxin.
Thomas AG; Vornov JJ; Olkowski JL; Merion AT; Slusher BS
J Pharmacol Exp Ther; 2000 Oct; 295(1):16-22. PubMed ID: 10991955
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury.
Slusher BS; Vornov JJ; Thomas AG; Hurn PD; Harukuni I; Bhardwaj A; Traystman RJ; Robinson MB; Britton P; Lu XC; Tortella FC; Wozniak KM; Yudkoff M; Potter BM; Jackson PF
Nat Med; 1999 Dec; 5(12):1396-402. PubMed ID: 10581082
[TBL] [Abstract][Full Text] [Related]
4. Blockade of NAALADase: a novel neuroprotective strategy based on limiting glutamate and elevating NAAG.
Vornov JJ; Wozniak K; Lu M; Jackson P; Tsukamoto T; Wang E; Slusher B
Ann N Y Acad Sci; 1999; 890():400-5. PubMed ID: 10668445
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation.
Thomas AG; Olkowski JL; Slusher BS
Eur J Pharmacol; 2001 Aug; 426(1-2):35-8. PubMed ID: 11525768
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia.
Cai Z; Lin S; Rhodes PG
Eur J Pharmacol; 2002 Feb; 437(3):139-45. PubMed ID: 11890901
[TBL] [Abstract][Full Text] [Related]
7. Design and pharmacological activity of phosphinic acid based NAALADase inhibitors.
Jackson PF; Tays KL; Maclin KM; Ko YS; Li W; Vitharana D; Tsukamoto T; Stoermer D; Lu XC; Wozniak K; Slusher BS
J Med Chem; 2001 Nov; 44(24):4170-5. PubMed ID: 11708918
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling of the interactions of glutamate carboxypeptidase II with its potent NAAG-based inhibitors.
Rong SB; Zhang J; Neale JH; Wroblewski JT; Wang S; Kozikowski AP
J Med Chem; 2002 Sep; 45(19):4140-52. PubMed ID: 12213057
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta.
Thomas AG; Liu W; Olkowski JL; Tang Z; Lin Q; Lu XC; Slusher BS
Eur J Pharmacol; 2001 Oct; 430(1):33-40. PubMed ID: 11698060
[TBL] [Abstract][Full Text] [Related]
10. Blockade of N-acetylaspartylglutamate peptidases: a novel protective strategy for brain injuries and neurological disorders.
Zhong C; Luo Q; Jiang J
Int J Neurosci; 2014 Dec; 124(12):867-73. PubMed ID: 24494725
[TBL] [Abstract][Full Text] [Related]
11. NAALADase inhibition protects motor neurons against chronic glutamate toxicity.
Thomas AG; Corse AM; Coccia CF; Bilak MM; Rothstein JD; Slusher BS
Eur J Pharmacol; 2003 Jun; 471(3):177-84. PubMed ID: 12826236
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons.
Tortella FC; Lin Y; Ved H; Slusher BS; Dave JR
Eur J Pharmacol; 2000 Aug; 402(1-2):31-7. PubMed ID: 10940354
[TBL] [Abstract][Full Text] [Related]
13. Measurement of glutamate carboxypeptidase II (NAALADase) enzyme activity by the hydrolysis of [³H]-N-acetylaspartylglutamate (NAAG).
Tiffany CW; Slusher BS
Curr Protoc Pharmacol; 2002 Feb; Chapter 3():Unit3.10. PubMed ID: 21959764
[TBL] [Abstract][Full Text] [Related]
14. Spinal N-acetyl-alpha-linked acidic dipeptidase (NAALADase) inhibition attenuates mechanical allodynia induced by paw carrageenan injection in the rat.
Yamamoto T; Nozaki-Taguchi N; Sakashita Y
Brain Res; 2001 Aug; 909(1-2):138-44. PubMed ID: 11478930
[TBL] [Abstract][Full Text] [Related]
15. NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat.
Zhong C; Zhao X; Van KC; Bzdega T; Smyth A; Zhou J; Kozikowski AP; Jiang J; O'Connor WT; Berman RF; Neale JH; Lyeth BG
J Neurochem; 2006 May; 97(4):1015-25. PubMed ID: 16606367
[TBL] [Abstract][Full Text] [Related]
16. N-acetylaspartylglutamate (NAAG) is the probable mediator of axon-to-glia signaling in the crayfish medial giant nerve fiber.
Gafurov B; Urazaev AK; Grossfeld RM; Lieberman EM
Neuroscience; 2001; 106(1):227-35. PubMed ID: 11564432
[TBL] [Abstract][Full Text] [Related]
17. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains.
Tsai G; Passani LA; Slusher BS; Carter R; Baer L; Kleinman JE; Coyle JT
Arch Gen Psychiatry; 1995 Oct; 52(10):829-36. PubMed ID: 7575102
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase.
Jackson PF; Cole DC; Slusher BS; Stetz SL; Ross LE; Donzanti BA; Trainor DA
J Med Chem; 1996 Jan; 39(2):619-22. PubMed ID: 8558536
[TBL] [Abstract][Full Text] [Related]
19. Competitive inhibition of N-acetylated-alpha-linked acidic dipeptidase activity by N-acetyl-L-aspartyl-beta-linked L-glutamate.
Serval V; Barbeito L; Pittaluga A; Cheramy A; Lavielle S; Glowinski J
J Neurochem; 1990 Jul; 55(1):39-46. PubMed ID: 2355230
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
